In vitro factors affecting the concentration of gamma-LpE (γ-LpE) in human plasma

Gamma-LpE (γ-LpE), a sphingomyelin-rich lipoprotein that contains apolipoprotein (apo) E as its only protein component, has been proposed to play a role in cellular cholesterol efflux by acting, like pre-β1-LpA-I, as an initial acceptor of cell-derived cholesterol. In order to further characterize t...

Full description

Bibliographic Details
Main Authors: Larbi Krimbou, Michel Tremblay, Hélène Jacques, Jean Davignon, Jeffrey S. Cohn
Format: Article
Language:English
Published: Elsevier 1998-04-01
Series:Journal of Lipid Research
Subjects:
HDL
Online Access:http://www.sciencedirect.com/science/article/pii/S0022227520325724
id doaj-0d1c0fabce544f01a58e30ebd7c33b69
record_format Article
spelling doaj-0d1c0fabce544f01a58e30ebd7c33b692021-04-26T05:46:19ZengElsevierJournal of Lipid Research0022-22751998-04-01394861872In vitro factors affecting the concentration of gamma-LpE (γ-LpE) in human plasmaLarbi Krimbou0Michel Tremblay1Hélène Jacques2Jean Davignon3Jeffrey S. Cohn4Hyperlipidemia and Atherosclerosis Research Group, Clinical Research Institute of Montreal, Montreal, Quebec, Canada H2W 1R7Hyperlipidemia and Atherosclerosis Research Group, Clinical Research Institute of Montreal, Montreal, Quebec, Canada H2W 1R7Hyperlipidemia and Atherosclerosis Research Group, Clinical Research Institute of Montreal, Montreal, Quebec, Canada H2W 1R7Hyperlipidemia and Atherosclerosis Research Group, Clinical Research Institute of Montreal, Montreal, Quebec, Canada H2W 1R7To whom correspondence should be addressed.; Hyperlipidemia and Atherosclerosis Research Group, Clinical Research Institute of Montreal, Montreal, Quebec, Canada H2W 1R7Gamma-LpE (γ-LpE), a sphingomyelin-rich lipoprotein that contains apolipoprotein (apo) E as its only protein component, has been proposed to play a role in cellular cholesterol efflux by acting, like pre-β1-LpA-I, as an initial acceptor of cell-derived cholesterol. In order to further characterize the presence of γ-LpE in human plasma, we have separated γ-LpE by two-dimensional non-denaturing polyacrylamide-gradient gel electrophoresis and detected its presence by immunoblotting with 125I-labeled polyclonal anti-apoE antibody. Five species of γ-LpE were routinely detected in human plasma, ranging in mean particle diameter from 9.5 to 16.5 nm. The largest proportion of γ-migrating apoE was associated with γ2-LpE having a diameter of 13.0 nm. Neither the amount of γ-LpE apoE (representing less than 1–2% of total plasma apoE) nor the number of γ-LpE subfractions was different in serum vs. plasma, or was affected by the presence of agents able to inhibit protein dimerization. γ-LpE subfractions were present in the plasma of patients having different apoE phenotypes (i.e., apoE 2/2, 3/3, or 4/4). Incubation of plasma at 37°C (90 min) caused a significant decrease in plasma γ-LpE (>80%) that was not dependent on LCAT or CETP activity. Storage (at –70°C) of hypertriglyceridemic but not normolipidemic plasma resulted in an increase in γ-LpE. Freezing of postprandial plasma samples, containing increased amounts of triglyceride-rich lipoproteins (TRL) enriched in apoE, also caused an increase in γ-LpE. Incubation of VLDL (d < 1.006 g/ml) with lipase resulted in the production of γ-migrating apoE. These results demonstrate that: 1) different γ-LpE subfractions exist in human plasma; 2) the amount of apoE associated with γ-LpE subfractions is dependent on in vitro conditions of plasma storage; and 3) TRL can act as a source of γ-LpE apoE in vitro.—Krimbou, L., M. Tremblay, H. Jacques, J. Davignon, and J. S. Cohn. In vitro factors affecting the concentration of gamma-LpE (γ-LpE) in human plasma. J. Lipid Res. 1998. 39: 861–872.http://www.sciencedirect.com/science/article/pii/S0022227520325724HDLcholesterol effluxapoE
collection DOAJ
language English
format Article
sources DOAJ
author Larbi Krimbou
Michel Tremblay
Hélène Jacques
Jean Davignon
Jeffrey S. Cohn
spellingShingle Larbi Krimbou
Michel Tremblay
Hélène Jacques
Jean Davignon
Jeffrey S. Cohn
In vitro factors affecting the concentration of gamma-LpE (γ-LpE) in human plasma
Journal of Lipid Research
HDL
cholesterol efflux
apoE
author_facet Larbi Krimbou
Michel Tremblay
Hélène Jacques
Jean Davignon
Jeffrey S. Cohn
author_sort Larbi Krimbou
title In vitro factors affecting the concentration of gamma-LpE (γ-LpE) in human plasma
title_short In vitro factors affecting the concentration of gamma-LpE (γ-LpE) in human plasma
title_full In vitro factors affecting the concentration of gamma-LpE (γ-LpE) in human plasma
title_fullStr In vitro factors affecting the concentration of gamma-LpE (γ-LpE) in human plasma
title_full_unstemmed In vitro factors affecting the concentration of gamma-LpE (γ-LpE) in human plasma
title_sort in vitro factors affecting the concentration of gamma-lpe (γ-lpe) in human plasma
publisher Elsevier
series Journal of Lipid Research
issn 0022-2275
publishDate 1998-04-01
description Gamma-LpE (γ-LpE), a sphingomyelin-rich lipoprotein that contains apolipoprotein (apo) E as its only protein component, has been proposed to play a role in cellular cholesterol efflux by acting, like pre-β1-LpA-I, as an initial acceptor of cell-derived cholesterol. In order to further characterize the presence of γ-LpE in human plasma, we have separated γ-LpE by two-dimensional non-denaturing polyacrylamide-gradient gel electrophoresis and detected its presence by immunoblotting with 125I-labeled polyclonal anti-apoE antibody. Five species of γ-LpE were routinely detected in human plasma, ranging in mean particle diameter from 9.5 to 16.5 nm. The largest proportion of γ-migrating apoE was associated with γ2-LpE having a diameter of 13.0 nm. Neither the amount of γ-LpE apoE (representing less than 1–2% of total plasma apoE) nor the number of γ-LpE subfractions was different in serum vs. plasma, or was affected by the presence of agents able to inhibit protein dimerization. γ-LpE subfractions were present in the plasma of patients having different apoE phenotypes (i.e., apoE 2/2, 3/3, or 4/4). Incubation of plasma at 37°C (90 min) caused a significant decrease in plasma γ-LpE (>80%) that was not dependent on LCAT or CETP activity. Storage (at –70°C) of hypertriglyceridemic but not normolipidemic plasma resulted in an increase in γ-LpE. Freezing of postprandial plasma samples, containing increased amounts of triglyceride-rich lipoproteins (TRL) enriched in apoE, also caused an increase in γ-LpE. Incubation of VLDL (d < 1.006 g/ml) with lipase resulted in the production of γ-migrating apoE. These results demonstrate that: 1) different γ-LpE subfractions exist in human plasma; 2) the amount of apoE associated with γ-LpE subfractions is dependent on in vitro conditions of plasma storage; and 3) TRL can act as a source of γ-LpE apoE in vitro.—Krimbou, L., M. Tremblay, H. Jacques, J. Davignon, and J. S. Cohn. In vitro factors affecting the concentration of gamma-LpE (γ-LpE) in human plasma. J. Lipid Res. 1998. 39: 861–872.
topic HDL
cholesterol efflux
apoE
url http://www.sciencedirect.com/science/article/pii/S0022227520325724
work_keys_str_mv AT larbikrimbou invitrofactorsaffectingtheconcentrationofgammalpeglpeinhumanplasma
AT micheltremblay invitrofactorsaffectingtheconcentrationofgammalpeglpeinhumanplasma
AT helenejacques invitrofactorsaffectingtheconcentrationofgammalpeglpeinhumanplasma
AT jeandavignon invitrofactorsaffectingtheconcentrationofgammalpeglpeinhumanplasma
AT jeffreyscohn invitrofactorsaffectingtheconcentrationofgammalpeglpeinhumanplasma
_version_ 1721508737535967232